These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8641136)

  • 21. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
    Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
    Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript.
    Algar EM; Kenney MT; Simms LA; Smith SI; Kida Y; Smith PJ
    Hum Mutat; 1995; 5(3):221-7. PubMed ID: 7599632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
    Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
    Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of nuclear localization signals within the zinc fingers of the WT1 tumor suppressor gene product.
    Bruening W; Moffett P; Chia S; Heinrich G; Pelletier J
    FEBS Lett; 1996 Sep; 393(1):41-7. PubMed ID: 8804420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation.
    Hewitt SM; Fraizer GC; Wu YJ; Rauscher FJ; Saunders GF
    J Biol Chem; 1996 Apr; 271(15):8588-92. PubMed ID: 8621487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1.
    Goodyer P; Dehbi M; Torban E; Bruening W; Pelletier J
    Oncogene; 1995 Mar; 10(6):1125-9. PubMed ID: 7700638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
    Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
    Zhang X; Xing G; Saunders GF
    Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Software and database for the analysis of mutations in the human WT1 gene.
    Jeanpierre C; Béroud C; Niaudet P; Junien C
    Nucleic Acids Res; 1998 Jan; 26(1):271-4. PubMed ID: 9399851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.
    Maheswaran S; Englert C; Bennett P; Heinrich G; Haber DA
    Genes Dev; 1995 Sep; 9(17):2143-56. PubMed ID: 7657166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The third zinc finger of the WT1 gene is mutated in Wilms' tumour but not in a broad range of other urogenital tumours.
    Quek HH; Chow VT; Tock EP
    Anticancer Res; 1993; 13(5A):1575-80. PubMed ID: 8239537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A far upstream cis-element is required for Wilms' tumor-1 (WT1) gene expression in renal cell culture.
    Scholz H; Bossone SA; Cohen HT; Akella U; Strauss WM; Sukhatme VP
    J Biol Chem; 1997 Dec; 272(52):32836-46. PubMed ID: 9407061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel replication inhibitory function of the developmental regulator/transcription repressor protein WT1 encoded by the Wilms' tumor gene.
    Anant S; Axenovich SA; Madden SL; Rauscher FJ; Subramanian KN
    Oncogene; 1994 Nov; 9(11):3113-26. PubMed ID: 7936634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor.
    Rauscher FJ
    FASEB J; 1993 Jul; 7(10):896-903. PubMed ID: 8393820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic organization of the human WT1 gene.
    Tadokoro K; Oki N; Fujii H; Ohshima A; Inoue T; Yamada M
    Jpn J Cancer Res; 1992 Nov; 83(11):1198-203. PubMed ID: 1483934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the DNA binding characteristics of the related zinc finger proteins WT1 and EGR1.
    Hamilton TB; Borel F; Romaniuk PJ
    Biochemistry; 1998 Feb; 37(7):2051-8. PubMed ID: 9485332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein.
    Madden SL; Cook DM; Rauscher FJ
    Oncogene; 1993 Jul; 8(7):1713-20. PubMed ID: 8510918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fusion of the EWS1 and WT1 genes as a result of the t(11;22)(p13;q12) translocation in desmoplastic small round cell tumors.
    Benjamin LE; Fredericks WJ; Barr FG; Rauscher FJ
    Med Pediatr Oncol; 1996 Nov; 27(5):434-9. PubMed ID: 8827070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma.
    Park S; Schalling M; Bernard A; Maheswaran S; Shipley GC; Roberts D; Fletcher J; Shipman R; Rheinwald J; Demetri G
    Nat Genet; 1993 Aug; 4(4):415-20. PubMed ID: 8401592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wilms' tumour gene and function.
    Hastie ND
    Curr Opin Genet Dev; 1993 Jun; 3(3):408-13. PubMed ID: 8353414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.